UPDATE 1-Proteon Therapeutics kidney drug fails key study, shares slump
Dec 13 (Reuters) - Proteon Therapeutics Inc said on Tuesday that its experimental chronic kidney disease drug failed to meet the main goal in a late-stage study, sending its shares plunging 70... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: study, kidney, Therapeutics, shares plunging, sending, late-stage, failed to, disease, chronic, experimental, on Tuesday, Proteon, (Reuters), slump, shares, fails, 1-Proteon, UPDATE
Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/cJo6SQdjeIM/proteon-study-idUSL4N1E83RZ